Financial News Feed

Stronger Sell Today ADMP ranks #3933 as SELL CANDIDATE. Weaker Sell
Today ADMP ranks #3933 as SELL CANDIDATE.

ADMP stock Adamis Pharmaceuticals Corporation

ADMP stock
Adamis Pharmaceuticals Corporation

The Percentage Price Oscillator has been recently spotted below the signal line on shares of Adamis Pharmaceuticl (ADMP). Traders watching these levels may be tracking the stock and watching for possi...

Read more

Adamis Pharmaceuticals (NASDAQ:ADMP) received a $10.00 price objective from investment analysts at Maxim Group in a research report issued to clients and investors on Tuesday. The firm currently has a...

Read more

Major market players are buzzing over Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) as their share price hit $2.31 at the end of the most recent trading session. Market capitalization is the total ...

Read more

Reiterated Adamis Pharma (NASDAQ:ADMP) Rating.The $10 target on the $109.72M market cap company given by Equities researchers at Maxim Group means a potential...

Read more

Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) Ratings CoverageIn total 2 analysts cover Adamis Pharmaceuticals (NASDAQ:ADMP)....

Read more

Putting the focus on shares of Adamis Pharmaceuticl (ADMP) we have noted that the stock price has dropped -26.60% over the last month. Looking back over the last half-year, we can see that the stock h...

Read more

Investors might be looking to focus on some longer-term indicators on shares of Adamis Pharmaceuticl (ADMP). The 100-day moving average verse price signal is Sell. This is the signal from the 100-day ...

Read more

Adamis Pharma (NASDAQ:ADMP) Rating Professional analysts at Raymond James have $6.7 target price on Adamis Pharma (NASDAQ:ADMP). Raymond James's target price Assembly Biosciences Inc (NASDAQ:ASMB) had...

Read more

Adamis Pharmaceuticals Corp (NASDAQ:ADMP) – Stock analysts at B. Riley issued their Q1 2019 EPS estimates for shares of Adamis Pharmaceuticals in a note issued to investors on Monday, March 18th. B....

Read more

Maxim Group set a $10.00 price objective on Adamis Pharmaceuticals (NASDAQ:ADMP) in a research report sent to investors on Tuesday morning. The brokerage currently has a buy rating on the specialty ph...

Read more

Adamis Pharmaceuticals Corporation (NASDAQ:ADMP)'s earnings release is anticipated by WallStreet on March, 21, according to Zacks. Analysts forecast $-0.19...

Read more

Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) had a decrease of 8.95% in short interest. ADMP’s SI was 3.53 million shares in March as released by FINRA. Its down 8.95% from 3.87M shares previous...

Read more

Analysts expect Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) to report $-0.19 EPS on March, 21.They anticipate $0.05 EPS change or 20.83% from last quarter’s $-0.24 EPS. After having $-0.21 EPS ...

Read more

Shares of Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) have been on a recent steady downtrend, causing some worry for shareholders. Stock market investing can sometimes become highly emotional. Be...

Read more

Adamis Pharmaceuticl (ADMP) are in trader’s focus this week as the Schaff Trend Cycle indicator has trending lower consistently over the past week. Investors will be watching to see if the price lev...

Read more

News Feed powered by

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank